← Back to Search

Behavioral Intervention

Education Video for Reducing Infections

N/A

Recruiting

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients admitted to an intervention unit who require a CHG skin treatment

Must not have

Patients on comfort care

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to use a short medical video to educate hospitalized patients on the importance of Chlorhexidine gluconate (CHG) bathing in reducing infections. The study will evaluate if using videos can

Who is the study for?

This trial is for hospitalized patients who need CHG skin treatment to prevent bloodstream infections. It's not for those with a history of CHG allergy or patients receiving end-of-life comfort care.

What is being tested?

The study tests the effectiveness of an educational video on how and why to perform CHG bathing, which helps reduce infection risks in hospitalized patients with central lines.

What are the potential side effects?

Since this intervention involves education through video without direct medical treatment, there are no physical side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need a CHG skin treatment in the hospital.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am receiving care focused on my comfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percentage of patients with a documented chlorhexidine gluconate bath documentation compliance

Secondary study objectives

Patient use of CHG skin treatment video

Patient-centered outcome questionnaire

Rate of central line associated bloodstream infections per 1000 central line days

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Intervention Group: In addition to the current educational document available for CHG bathing, patients in the intervention group would be provided access to a CHG bathing video through multiple avenues (QR codes placed in the room/unit, video provided on unit iPads). Nurses will be instructed to provide QR codes to patients to scan and watch the video. Patients can scan the QR code using their own smart device or through unit-based iPads. After viewing the video, there is another QR code to scan that goes to a short patient survey.

Group II: Control GroupActive Control1 Intervention

Control Group: Patients in the control group would have access to the current education available (patient education document) - usual care

0 / 2Eligibility criteria met